Additional file 6 of DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome
dataset
posted on 2021-01-07, 04:41 authored by L. C. Schenkel, E. Aref-Eshghi, K. Rooney, J. Kerkhof, M. A. Levy, H. McConkey, R. C. Rogers, K. Phelan, S. M. Sarasua, L. Jain, R. Pauly, L. Boccuto, B. DuPont, G. Cappuccio, N. Brunetti-Pierri, C. E. Schwartz, B. SadikovicAdditional file 6: Table S5. Statistical comparison of metabolite profiles. Results of the statistical comparisons for metabolite levels comparing control lymphoblastoid cell lines (LCLs) to the cell lines from individuals with small 22q13 deletions (< 1 Mb) or pathogenic variants of SHANK3 and to the cell lines from the individuals with large deletions. These include mean metabolite levels, p value, and adjusted p value.
